CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2025
0mins
Source: Businesswire
Investigation of Proposed Sale: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the proposed sale of Chimerix, Inc. to Jazz Pharmaceuticals, where shareholders would receive $8.55 per share.
Legal Rights Inquiry: KSF is assessing whether the sale price adequately reflects the company's value and invites shareholders to discuss their legal rights regarding the transaction.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
